Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.

Behl D, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, Inwards DJ, White WL, Ansell SM, Micallef IN, Johnston PB, Porrata LF.

Br J Haematol. 2007 Jun;137(5):409-15. Epub 2007 Apr 13.

PMID:
17433025
2.

Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O.

J Natl Cancer Inst. 2009 Feb 18;101(4):248-55. doi: 10.1093/jnci/djn478. Epub 2009 Feb 10. Review.

3.

Rituximab maintenance therapy in indolent NHL: a clinical review.

Buske C, Hiddemann W.

Leuk Res. 2006 Mar;30 Suppl 1:S11-5. Review.

PMID:
16750673
4.

Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival.

Turturro F.

Expert Rev Anticancer Ther. 2007 Jul;7(7):959-65. Review.

PMID:
17627454
5.

Rituximab maintenance therapy: a step forward in follicular lymphoma.

van Oers MH.

Haematologica. 2007 Jun;92(6):826-33. Review.

6.

Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.

Ling HT, Field JJ, Blinder MA.

Am J Hematol. 2009 Jul;84(7):418-21. doi: 10.1002/ajh.21439. Review.

7.

Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.

Buchegger F, Press OW, Delaloye AB, Ketterer N.

Oncologist. 2008 Jun;13(6):657-67. doi: 10.1634/theoncologist.2008-0020. Review.

8.

Maintenance therapy for low-grade lymphomas: has the time come?

Cartron G, Solal-Céligny P.

Curr Opin Oncol. 2007 Sep;19(5):425-32. Review.

PMID:
17762565
9.

Treatment of follicular lymphoma: current status.

Tilly H, Zelenetz A.

Leuk Lymphoma. 2008;49 Suppl 1:7-17. doi: 10.1080/10428190802311391. Review.

PMID:
18821428
10.

Safety of rituximab maintenance therapy in follicular lymphomas.

Solal-Céligny P.

Leuk Res. 2006 Mar;30 Suppl 1:S16-21. Review.

PMID:
16750674
11.

How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?

Illidge T, Chan C.

Leuk Lymphoma. 2008 Jul;49(7):1263-73. doi: 10.1080/10428190802090805. Review.

PMID:
18604715
12.

Patient benefits of maintenance immunotherapy.

Ghielmini M.

Leuk Res. 2006 Mar;30 Suppl 1:S22-6. Review.

PMID:
16750675
13.

Treatment of follicular and other indolent lymphomas.

McLaughlin P.

Curr Opin Oncol. 1999 Sep;11(5):333-8. Review.

PMID:
10505768
14.

Principles of maintenance therapy.

Berinstein NL.

Leuk Res. 2006 Mar;30 Suppl 1:S3-10. Review.

PMID:
16750676
15.

Controversies in follicular lymphoma: "who, what, when, where, and why?" (not necessarily in that order!).

Czuczman MS.

Hematology Am Soc Hematol Educ Program. 2006:303-10. Review.

PMID:
17124076
Items per page

Supplemental Content

Write to the Help Desk